Microfluidic Single-Cell Assay for Antibody Secretion Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional bulk cellular analyses mask cellular heterogeneity, making it difficult to isolate and study unique cell types, particularly antibody-secreting cells, due to low purity and dilution of secreted antibodies, which hampers the discovery of therapeutic antibodies.
Innovation Solution
A microfluidic platform is used to analyze extracellular effects of single effector cells, such as antibody-secreting cells, by retaining a cell population in a microreactor with readout cells, assaying for agonist or antagonist effects on cell surface receptors or ion channels, and recovering cells for further characterization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional bulk cellular analyses are used to measure cellular processes, then large numbers of cells can be analyzed simultaneously, but cellular heterogeneity is masked and underlying biological features of individual cells are obscured
Solution Approach 1:
The invention divides the bulk cell population into individual single-cell compartments within a microfluidic array. Each compartment contains a single cell or a very small number of cells, allowing individual cell analysis while maintaining high throughput through parallel processing of thousands of compartments simultaneously. This segmentation resolves the contradiction by enabling both high productivity and precise measurement of individual cell features.
Solution Approach 2:
The invention creates multiple copies of the same assay condition across thousands of identical microfluidic compartments, each containing a single cell. This allows parallel measurement of the same biological question across many cells simultaneously, maintaining high throughput while preserving individual cell data integrity. The replicated compartments enable statistical analysis while keeping each individual cell's characteristics intact.
2Measurement precision
If existing methods for isolating populations of unique cell types are used, then cell populations can be separated, but functional purity is limited and molecular signatures are obscured by contamination from other cell types
Solution Approach 1:
The invention extracts and isolates individual cells from the bulk population and places them into separate microfluidic compartments. This extraction process achieves high functional purity by ensuring that each compartment contains only the cell of interest, eliminating contamination from other cell types. The microfluidic system enables this extraction at high throughput without increasing operational complexity.
Solution Approach 2:
The invention replaces complex mechanical cell sorting systems with a microfluidic-based isolation method. Instead of using sophisticated mechanical sorters that require complex infrastructure, the patent uses simple microfluidic channels and chambers that can be integrated into standard laboratory equipment, achieving high purity while reducing device complexity.
3Measurement precision
If single cell assay platforms are used to study individual cells, then cellular heterogeneity can be detected, but throughput is limited and rare cells with unique properties are difficult to isolate
Solution Approach 1:
The invention merges the advantages of single-cell analysis with high-throughput capabilities by integrating thousands of single-cell compartments into a single microfluidic array. This allows simultaneous analysis of individual cells at the precision level required for detecting heterogeneity while maintaining the throughput of bulk analysis through parallel processing. The merged system processes many cells in parallel without sacrificing single-cell resolution.
Solution Approach 2:
The invention transitions from analyzing cells in a single dimension (either bulk or individual) to a multi-dimensional approach where thousands of single cells are analyzed in parallel across multiple spatial dimensions within the microfluidic array. This dimensional expansion enables both high throughput and high precision by distributing individual cell analyses across many parallel compartments while maintaining individual resolution through careful design of the microfluidic architecture.
4Productivity
If antibody-secreting cells are analyzed in bulk population, then high throughput data can be obtained, but secreted antibodies are diluted and difficult to detect
Solution Approach 1:
The invention segments the bulk cell population into individual single-cell compartments, which concentrates the secreted antibodies from each cell into a small, defined volume. This segmentation increases the local concentration of secreted antibodies while maintaining the ability to process many cells in parallel through the microfluidic array, thus resolving the contradiction between throughput and antibody concentration.
Solution Approach 2:
The invention changes the physical parameters of the assay by reducing the volume in which antibodies are secreted and detected. By confining each cell and its secreted products to a small microfluidic compartment, the system increases the local concentration of antibodies without requiring large volumes, thus enabling detection while maintaining high throughput through parallel processing.
Data Source
Figure 1~2
Figure 3~5
Figure 6~8
AI summary
Methods and devices are provided herein for identifying a cell population comprising an effector cell that exerts an extracellular effect. In one embodiment the method comprises retaining in a microreactor a cell population comprising one or more effector cells, wherein the contents of the microreactor further comprise a readout particle population comprising one or more readout particles, incubating the cell population and the readout particle population within the microreactor, assaying the cell population for the presence of the extracellular effect, wherein the readout particle population or subpopulation thereof provides a direct or indirect readout of the extracellular effect, and determining, based on the results of the assaying step, whether one or more effector cells within the cell population exerts the extracellular effect on the readout particle. If an extracellular effect is measured, the cell population is recovered for further analysis to determine the cell or cells responsible for the effect.